The Chemours Co (CC)

15.13
NYSE : Basic Materials
Prev Close 14.99
Day Low/High 14.87 / 15.29
52 Wk Low/High 3.06 / 15.04
Avg Volume 3.38M
Exchange NYSE
Shares Outstanding 181.55M
Market Cap 2.72B
P/E Ratio N/A
Div & Yield 0.12 (0.80%)

Latest News

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.

Anything These Guys Are Selling, I'm not Buying

Anything These Guys Are Selling, I'm not Buying

When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.

Chemours Board Member Recognized by Savoy Magazine for Business Leadership

Chemours Board Member Recognized by Savoy Magazine for Business Leadership

Dr. Curtis J. Crawford Named to Prestigious List of 2016 Most Influential Black Corporate Directors

Insiders Seeing Green With CC At New 52-Week High

Insiders Seeing Green With CC At New 52-Week High

In trading on Thursday, shares of Chemours Co touched a new 52-week high of $11.66/share. That's a 281.05% rise, or $8.6 per share from the 52-week low of $3.06 set back on 01/27/2016.

Chemours (CC) Stock Rises, Upgraded After Q2 Earnings Beat

Chemours (CC) Stock Rises, Upgraded After Q2 Earnings Beat

Chemours' (CC) stock rating was boosted at Argus on Wednesday after the company's stronger-than-anticipated earnings for the 2016 second quarter.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, ACM, ACTS, BID, CC, COH, COKE, DSCI, EGRX, FNV, NWS, SHO, SSNC Downgrades: AMBC, HHC, HLF, LXFR, ROG, TCP Initiations: APLE, CNXR, EKSO, GNL, HLTH, LIND Read on to get TheStreet Quant Ratings' detailed report:

Chemours (CC) Stock Soars After Q2 Earnings Beat

Chemours (CC) Stock Soars After Q2 Earnings Beat

Chemours (CC) stock was trading sharply higher mid-Tuesday morning after reporting mixed results for the 2016 second quarter.

Strong On High Volume: Chemours (CC)

Strong On High Volume: Chemours (CC)

Trade-Ideas LLC identified Chemours (CC) as a strong on high relative volume candidate

Icynene Innovates With Opteon™ 1100 Foam Blowing Agent From Chemours

Icynene Innovates With Opteon™ 1100 Foam Blowing Agent From Chemours

Icynene Will Use Opteon™ 1100 to Develop New Polyurethane Spray Foam Products Delivering Superior Insulation and Lower Global Warming Impact

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DRH, LBTYB, REXR, STFC Downgrades: NWLI, VLP Initiations: CC, FOGO Read on to get TheStreet Quant Ratings' detailed report:

FB, GOOGL, C: Jim Cramer's Views

FB, GOOGL, C: Jim Cramer's Views

Cramer shares his views on how the market rallying is good news for some stocks. Facebook, Google and Citigroup are among the stocks discussed.

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Wall Street closed out the holiday-shortened week with a bang.

S&P 500 Soars to Near Record Close as Jobs Report Brings Relief Over U.S. Economy

S&P 500 Soars to Near Record Close as Jobs Report Brings Relief Over U.S. Economy

Wall Street closed out the holiday-shortened week with a bang. Stocks bagged major gains after a blowout jobs report brought relief over the state of the U.S. economy.

S&P 500 Hovers at Records as Jobs Report Brings Economic Confidence

S&P 500 Hovers at Records as Jobs Report Brings Economic Confidence

Stocks jump Friday after a blockbuster jobs report assures investors recent weakness was an aberration.

Chemours (CC) Stock Surges on Light Punitive Damages in DuPont Case

Chemours (CC) Stock Surges on Light Punitive Damages in DuPont Case

Chemours (CC) stock is rising today after a jury assigned just $500,000 in punitive damages to DuPont in a chemical dumping case.

Cramer: Amazon Hits All-Time High Without Retail Folding

And that's distinctly good news for the overall market.

Chemours Signs Definitive Agreement To Sell Sulfur Products To Veolia

Chemours Signs Definitive Agreement To Sell Sulfur Products To Veolia

Agreement Marks Completion of Chemical Solutions Portfolio Review--Part of Chemours Transformation Plan

'Mad Money' Lightning Round: Take Lowe's Over Lumber Liquidators

'Mad Money' Lightning Round: Take Lowe's Over Lumber Liquidators

Crmer prefers Nvidia over Western Digital and LAM Research over Micron Technology.

Jim Cramer's 'Mad Money' Recap: The Bull Is Napping

Jim Cramer's 'Mad Money' Recap: The Bull Is Napping

The rally has been strong and the bull market is taking a deserved rest, Cramer says.

Here’s Short-Seller Andrew Left’s Latest Target

Here’s Short-Seller Andrew Left’s Latest Target

Shares of Chemours plunged on Friday on the heels of a bearish report written by short-seller Andrew Left of Citron Research.

Trending Tickers: SBUX , CC, BAC, ETFC, DNKN

U.S. markets falter Friday after an especially weak jobs report. 

Chemours (CC) Stock Continues Slide, Issues Response to Citron Report

Chemours (CC) Stock Continues Slide, Issues Response to Citron Report

Chemours (CC) stock is down from yesterday after a Citron report said the company was 'purposely designed for bankruptcy,' Chemours issued a response to that claim.

Short-Seller Cites 'Evil' of DuPont Spinoff Chemours

Andrew Left says he feels 'guilty' bringing up the stock issue when the humanitarian issue is much bigger.